Explore / Clinical trial
Clinical trial

Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism

Yale UniversityCompletedPhase 1Started Dec 1, 200733 enrolledUnited StatesNCT02675530

Abstract

This study investigates the common features of electrophysiological measures in schizophrenia and effects of NMDA antagonist ketamine in healthy volunteers.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

NMDAglutamateschizophreniaSchizophrenia

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.